CEREBROSPINAL FLUID IN NEUROLOGIC DISORDERS. VOLUME 146

• Section I. General Aspects
1. The use of cerebrospinal fluid in biomarker studies
2. The cerebrospinal fluid and barriers - anatomical and physiological considerations
3. More than a drainage fluid: the role of CSF in signalling in the brain and other effects on brain tissue
4. Dosing, collection and quality control issues in cerebrospinal fluid research using animal models
• Section II. CSF Research in Particular Disease Entities and its Clinical Context
5. Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system
6. Cerebrospinal fluid in the dementias
7. Biomarkers in cerebrospinal fluid for synucleinopathies, tauopathies, and other neurodegenerative disorders
8. Cerebrospinal fluid in Creutzfeld-Jakob disease
9. Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies
10. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system
11. Impaired cerebrospinal fluid pressure
12. Cerebrospinal fluid in acute and chronic infectious diseases
13. Vascular diseases and bleedings
14. Cerebrospinal fluid and brain extracellular fluid in severe brain trauma
15. Epilepsy
16. Primary headaches
17. Psychiatric syndromes other than dementia

• Provides a brief overview on the current use of CSF in clinical routine, the physiology of CSF, and its usefulness and potential as a biomarker
• Addresses relevant research in context with the most important diagnostic entities in neurology
• Edited by leading authors in CSF research from around the globe, presenting the broadest, most expert coverage available

Authors
• Florian Deisenhammer, Neuroimmunology Laboratory, Innsbruck Medical University, Innsbruck, Austria ;
• Charlotte E. Teunissen, Neurochemistry Lab and Biobank, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
• Hayrettin Tumani, Department of Neurology, University of Ulm, Ulm, Germany